William D. Paiva, PhD, is manager of the Oklahoma Life Science Fund which makes investments in medical diagnostic and device, technology enabled health care service, and therapeutic companies.  In addition, Dr. Paiva is Executive Director of Oklahoma State University’s Center for Health Systems Innovation (CHSI). The Center is focused on transforming rural and Native America health through the implementation of innovative care delivery and IT solutions.  Within CHSI, the Institute for Care Delivery focuses on developing new and innovative care delivery and business models for rural and Native American markets and the Institute for Predictive Medicine is applying advanced analytics to the largest health care database which includes clinical information for over 63 million patients covering 16 years.

Prior to his current positions, William was a partner with Sevin Rosen Funds where he specialized in identifying early-stage venture opportunities at the intersection of traditional technology sectors and healthcare.  He was also a partner at Chisholm Private Capital Partners, where he managed a $100 million fund focused on healthcare and IT. In addition, William served as a management consultant for the Life Sciences Industry Group at Pittiglio Rabin Todd & McGrath, later acquired by PriceWaterhouseCoopers, where he consulted with the top five pharmaceutical companies on product-development and technology-management projects. He also served as an investment banking associate at JP Morgan in New York, providing strategic and investment banking advisory services to Fortune 100 healthcare companies.

William holds a Ph.D. in molecular biology from the University of Oklahoma; an MBA from Dartmouth College’s Amos Tuck School of Business; an MS in microbiology and immunology from the University of Oklahoma Health Science Center; and a BS in microbiology from the University of Oklahoma.